Abcam collaborates with twist bioscience to enhance antibody discovery for diagnostic and research applications

Cambridge, england & south san francisco, calif.--(business wire)--twist bioscience corporation (nasdaq:twst), a company enabling customers to succeed through its offering of high-quality synthetic dna using its silicon platform, and abcam (aim:abc; nasdaq:abcm), a global innovator in life sciences reagents and tools, today announced a licensing agreement under which abcam will use a proprietary twist vhh phage library for antibody discovery, development and commercialization for diagnostic and
ABCM Ratings Summary
ABCM Quant Ranking